Abedin, Laga .

HRN: 26-16-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/04/2024
12/11/2024
IV
2.25g
Every 8hours
Complicated UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: